Derek Hicks

Insider Reports History

Location
Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Derek Hicks:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Business Officer Common Stock 59,878 $729,314 $12.18 03 Jan 2025 Direct
Intellia Therapeutics, Inc. EVP, Chief Business Officer Stock Option (right to buy) 42,421 01 Mar 2024 Direct

Insider Reports Filed by Derek Hicks

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 03 Jan 2025 1 -$79,194 4 EVP, Chief Business Officer 07 Jan 2025, 17:20
NTLA Intellia Therapeutics, Inc. 01 Mar 2024 2 $0 4 EVP, Chief Business Officer 05 Mar 2024, 16:10
NTLA Intellia Therapeutics, Inc. 03 Jan 2024 1 -$114,216 4 EVP, Chief Business Officer 05 Jan 2024, 16:46
NTLA Intellia Therapeutics, Inc. 01 Mar 2023 2 $0 4 EVP, Chief Business Officer 03 Mar 2023, 16:31
NTLA Intellia Therapeutics, Inc. 04 Jan 2023 1 -$67,425 4 EVP, Chief Business Officer 06 Jan 2023, 16:29
NTLA Intellia Therapeutics, Inc. 03 Jan 2022 2 $0 4 EVP, Chief Business Officer 05 Jan 2022, 15:15
NTLA Intellia Therapeutics, Inc. 20 Dec 2021 0 $0 3 EVP, Chief Business Officer 29 Dec 2021, 15:20